Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zentek has commercialized its ZenGUARD™ graphene-silver antimicrobial coating in surgical masks and HVAC filters with Health Canada approval. The company’s subsidiary Triera Biosciences received a government contract to test its multivalent aptamer technology as a rapid drug discovery platform against highly pathogenic avian influenza. In vitro data show strong broad-spectrum antimicrobial activity of their coatings. Clinical results are not yet available for therapeutic programs; diagnostic products are in advanced development or pilot use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zentek.